Nano-sized MRI contrast agents with dendrimer cores

Advanced Drug Delivery Reviews

Volumn 57, Issue 15, 2005, Pages 2271-2286

  Kobayashi, Hisataka ^a   Brechbiel, Martin W ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Contrast agent; Dendrimer; Magnetic resonance imaging; Nano size; Paramagnetic; Polymer

Indexed keywords

BLOOD; COMPUTERIZED TOMOGRAPHY; GADOLINIUM; HYDROPHILICITY; HYDROPHOBICITY; MAGNETIC RESONANCE IMAGING; PARAMAGNETISM;

CONTRAST AGENT; GADOLINIUM IONS; NANO SIZE;

DENDRIMERS;

1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID; 2 (4 ISOTHIOCYANATOBENZYL) 6 METHYLDIETHYLENETRIAMINE PENTAACETIC ACID; ACETIC ACID DERIVATIVE; AVIDIN; CONTRAST MEDIUM; DENDRIMER; ECHOVIST; GADOBENATE DIMEGLUMINE; GADODIAMIDE; GADOLINIUM; GADOLINIUM PENTETATE; IBRITUMOMAB TIUXETAN; IODINE; LIPOSOME; MACROGOL; MONOCLONAL ANTIBODY; NANOPARTICLE; PENTETIC ACID; POLYAMIDOAMINE; POLYAMIDOAMINE G10; POLYAMIDOAMINE G2; POLYAMIDOAMINE G3; POLYAMIDOAMINE G4; POLYAMIDOAMINE G5; POLYAMIDOAMINE G6; POLYAMIDOAMINE G7; POLYAMIDOAMINE G8; POLYAMIDOAMINE G9; POLYPROPYLENIMINE DIAMINOBUTANE; UNCLASSIFIED DRUG;

BLOOD VESSEL PERMEABILITY; COMPARATIVE STUDY; CONTRAST ENHANCEMENT; DRUG CLEARANCE; DRUG CONJUGATION; DRUG EXCRETION; DRUG LIVER LEVEL; HYDROPHILICITY; HYDROPHOBICITY; KIDNEY FUNCTION; LYMPHATIC SYSTEM; MACROMOLECULE; MOLECULAR WEIGHT; NEUTRON CAPTURE THERAPY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; RADIOIMMUNOTHERAPY; RETICULOENDOTHELIAL SYSTEM; REVIEW;

ANIMALS; CONTRAST MEDIA; HUMANS; MAGNETIC RESONANCE IMAGING; NANOSTRUCTURES; PARTICLE SIZE;

EID: 28744441712     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.addr.2005.09.016     Document Type: Review

References (87)

1. M.D. Ogan, U. Schmiedl, M.E. Moseley, W. Grodd, H. Paajanen, and R.C. Brasch Albumin labeled with Gd-DTPA. An intravascular contrast-enhancing agent for magnetic resonance blood pool imaging: preparation and characterization Invest. Radiol. 22 1987 665 671
2. F.M. Cohen, R. Kuwatsuru, D.M. Shames, M. Neuder, J.S. Mann, V. Vexler, W. Rosenau, and R.C. Brasch Contrast-enhanced magnetic resonance imaging estimation of altered capillary permeability in experimental mammary carcinomas after X-irradiation Invest. Radiol. 29 1994 970 977
3. R. Brasch, C. Pham, D. Shames, T. Roberts, K. van Dijke, N. van Bruggen, J. Mann, S. Ostrowitzki, and O. Melnyk Assessing tumor angiogenesis using macromolecular MR imaging contrast media J. Magn. Reson. Imaging 7 1997 68 74
4. M.G. Wikstrom, M.E. Moseley, D.L. White, J.W. Dupon, J.L. Winkelhake, J. Kopplin, and R.C. Brasch Contrast-enhanced MRI of tumors. Comparison of Gd-DTPA and a macromolecular agent Invest. Radiol. 24 1989 609 615
5. G. Schuhmann-Giampieri, H. Schmitt-Willich, T. Frenzel, W.R. Press, and H.J. Weinmann In vivo and in vitro evaluation of Gd-DTPA-polylysine as a macromolecular contrast agent for magnetic resonance imaging Invest. Radiol. 26 1991 969 974
6. V.S. Vexler, O. Clement, H. Schmitt-Willich, and R.C. Brasch Effect of varying the molecular weight of the MR contrast agent Gd-DTPA-polylysine on blood pharmacokinetics and enhancement patterns J. Magn. Reson. Imaging 4 1994 381 388
7. Y. Berthezene, V. Vexler, D.C. Price, J. Wisner-Dupon, M.E. Moseley, K.P. Aicher, and R.C. Brasch Magnetic resonance imaging detection of an experimental pulmonary perfusion deficit using a macromolecular contrast agent. Polylysine-gadolinium-DTPA40 Invest. Radiol. 27 1992 346 351
8. A.A. Bogdanov Jr., R. Weissleder, H.W. Frank, A.V. Bogdanova, N. Nossif, B.K. Schaffer, E. Tsai, M.I. Papisov, and T.J. Brady A new macromolecule as a contrast agent for MR angiography: preparation, properties, and animal studies Radiology 187 1993 701 706
9. S.C. Wang, M.G. Wikstrom, D.L. White, J. Klaveness, E. Holtz, P. Rongved, M.E. Moseley, and R.C. Brasch Evaluation of Gd-DTPA-labeled dextran as an intravascular MR contrast agent: imaging characteristics in normal rat tissues Radiology 175 1990 483 488
10. N. Siauve, O. Clement, C.A. Cuenod, S. Benderbous, and G. Frija Capillary leakage of a macromolecular MRI agent, carboxymethyldextran-Gd-DTPA, in the liver: pharmacokinetics and imaging implications Magn. Reson. Imaging 14 1996 381 390
11. P. Loubeyre, E. Canet, S. Zhao, S. Benderbous, M. Amiel, and D. Revel Carboxymethyl-dextran-gadolinium-DTPA as a blood-pool contrast agent for magnetic resonance angiography. Experimental study in rabbits Invest. Radiol. 31 1996 288 293
12. H. Frank, R. Weissleder, A.A. Bogdanov Jr., and T.J. Brady Detection of pulmonary emboli by using MR angiography with MPEG-PL-GdDTPA: an experimental study in rabbits AJR Am. J. Roentgenol. 162 1994 1041 1046
13. T.S. Desser, D.L. Rubin, H.H. Muller, F. Qing, S. Khodor, G. Zanazzi, S.W. Young, D.L. Ladd, J.A. Wellons, and K.E. Kellar Dynamics of tumor imaging with Gd-DTPA-polyethylene glycol polymers: dependence on molecular weight J. Magn. Reson. Imaging 4 1994 467 472
14. L. Harika, R. Weissleder, K. Poss, and M.I. Papisov Macromolecular intravenous contrast agent for MR lymphography: characterization and efficacy studies Radiology 198 1996 365 370
15. R. Weissleder, A. Bogdanov Jr., C.H. Tung, and H.J. Weinmann Size optimization of synthetic graft copolymers for in vivo angiogenesis imaging Bioconjug. Chem. 12 2001 213 219
16. G.R. Newkome, C.N. Moorefiled, and F. Vogtle G.R. Newkome Dendrimer and Dendrons, Concepts, Syntheses, Applications 2001 Wiley-V.C.H New York, NY
17. D.A. Tomalia, A.M. Naylor, and W.A. Goddard III Starburst dendrimers: molecular-level control of size, shape, surface chemistry, topology, and flexibility from atoms to macroscopic matter Angew Chem.-Int. Ed. 29 1990 138 175
18. N. Malik, R. Wiwattanapatapee, R. Klopsch, K. Lorenz, H. Frey, J.W. Weener, E.W. Meijer, W. Paulus, and R. Duncan Dendrimers: relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of 125I-labelled polyamidoamine dendrimers in vivo J. Control. Release 65 2000 133 148
19. C. Wu, M.W. Brechbiel, R.W. Kozak, and O.A. Gansow Metal-chelate- dendrimer-antibody constructs for use in radioimmunotherapy and imaging Bioorg. Med. Chem. Lett. 4 1994 449 454
20. E.C. Wiener, M.W. Brechbiel, H. Brothers, R.L. Magin, O.A. Gansow, D.A. Tomalia, and P.C. Lauterbur Dendrimer-based metal chelates: a new class of magnetic resonance imaging contrast agents Magn. Reson. Med. 31 1994 1 8
21. P. Singh, F. Moll III, S.H. Lin, C. Ferzli, K.S. Yu, R.K. Koski, R.G. Saul, and P. Cronin Starburst dendrimers: enhanced performance and flexibility for immunoassays Clin. Chem. 40 1994 1845 1849
22. R.F. Barth, D.M. Adams, A.H. Soloway, F. Alam, and M.V. Darby Boronated starburst dendrimer-monoclonal antibody immunoconjugates: evaluation as a potential delivery system for neutron capture therapy Bioconjug. Chem. 5 1994 58 66
23. H. Kobayashi, C. Wu, M.K. Kim, C.H. Paik, J.A. Carrasquillo, and M.W. Brechbiel Evaluation of the in vivo biodistribution of indium-111 and yttrium-88 labeled dendrimer-1B4M-DTPA and its conjugation with anti-Tac monoclonal antibody Bioconjug. Chem. 10 1999 103 111
24. H. Kobayashi, N. Sato, T. Saga, Y. Nakamoto, T. Ishimori, S. Toyama, K. Togashi, J. Konishi, and M.W. Brechbiel Monoclonal antibody-dendrimer conjugates enable radiolabeling of antibody with markedly high specific activity with minimal loss of immunoreactivity Eur. J. Nucl. Med. 27 2000 1334 1339
25. H. Kobayashi, and M.W. Brechbiel Gadolinium-based macromolecular MRI contrast agents Mol. Imaging 2 2003 1 10
26. H. Kobayashi, and M.W. Brechbiel Dendrimer-based nanosized MRI contrast agents Curr. Pharm. Biotechnol. 5 2004 539 549
27. B. Misselwitz, H. Schmitt-Willich, W. Ebert, T. Frenzel, and H.J. Weinmann Pharmacokinetics of Gadomer-17, a new dendritic magnetic resonance contrast agent Magma 12 2001 128 134
28. G. Staatz, E. Spuntrup, A. Buecker, B. Misselwitz, and R.W. Gunther T1-weighted MR-lymphography after intramammary administration of Gadomer-17 in pigs Rofo. Fortschr. Geb. Rontgenstr. Neuen. Bildgeb. Verfahr. 174 2002 29 32
29. Q. Dong, D.R. Hurst, H.J. Weinmann, T.L. Chenevert, F.J. Londy, and M.R. Prince Magnetic resonance angiography with gadomer-17. An animal study original investigation Invest. Radiol. 33 1998 699 708
30. W.K. Moon, K.H. Chang, H.J. Weinmann, Y.H. Koh, J.G. Im, K.M. Yeon, and M.C. Han Dynamic contrast-enhanced MR imaging of bacterial abscess and VX2 carcinoma in rabbits: comparison of gadopentetate dimeglumine and a macromolecular contrast agent AJR Am. J. Roentgenol. 174 2000 1385 1390
31. N. Sato, H. Kobayashi, A. Hiraga, T. Saga, K. Togashi, J. Konishi, and M.W. Brechbiel Pharmacokinetics and enhancement patterns of macromolecular MR contrast agents with various sizes of polyamidoamine dendrimer cores Magn. Reson. Med. 46 2001 1169 1173
32. H. Kobayashi, S. Kawamoto, S. Jo, L.H. Bryant Jr., M.W. Brechbiel, and R.A. Star Macromolecular MRI contrast agents with small dendrimers: pharmacokinetic differences between sizes and cores Bioconjug. Chem. 14 2003 388 394
33. L.D. Margerum, B.K. Campion, M. Koo, N. Shargill, J.J. Lai, A. Marumoto, and P.C. Sontum Gadolinium(III) DO3A macrocycles and polyethylene glycol coupled to dendrimers. Effect of molecular weight on physical and biological properties of macromolecular magnetic resonance imaging contrast agents J. Alloys Compd. 249 1997 185 190
34. N. Watanabe, D.A. Goodwin, C.F. Meares, M. McTigue, W. Chaovapong, C.M. Ransone, and O. Renn Immunogenicity in rabbits and mice of an antibody-chelate conjugate: comparison of (S) and (R) macrocyclic enantiomers and an acyclic chelating agent Cancer Res. 54 1994 1049 1054
35. H. Kobayashi, N. Sato, A. Hiraga, T. Saga, Y. Nakamoto, H. Ueda, J. Konishi, K. Togashi, and M.W. Brechbiel 3D-micro-MR angiography of mice using macromolecular MR contrast agents with polyamidoamine dendrimer core with references to their pharmacokinetic properties Magn. Reson. Med. 45 2001 454 460
36. H. Kobayashi, S. Kawamoto, T. Saga, N. Sato, A. Hiraga, J. Konishi, K. Togashi, and M.W. Brechbiel Micro-MR angiography of normal and intratumoral vessels in mice using dedicated intravascular MR contrast agents with high generation of polyamidoamine dendrimer core: reference to pharmacokinetic properties of dendrimer-based MR contrast agents J. Magn. Reson. Imaging 14 2001 705 713
37. G.A. Wiseman, C.A. White, M. Stabin, W.L. Dunn, W. Erwin, M. Dahlbom, A. Raubitschek, K. Karvelis, T. Schultheiss, T.E. Witzig, R. Belanger, S. Spies, D.H. Silverman, J.R. Berlfein, E. Ding, and A.J. Grillo-Lopez Phase I/II 90Y-Zevalin (yttrium-90 ibritumomab tiuxetan, IDEC-Y2B8) radioimmunotherapy dosimetry results in relapsed or refractory non-Hodgkin's lymphoma Eur. J. Nucl. Med. 27 2000 766 777
38. D.E. Milenic, and M.W. Brechbiel Targeting of radio-isotopes for cancer therapy Cancer Biol. Ther. 3 2004 361 370
39. G.A. Wiseman, C.A. White, T.E. Witzig, L.I. Gordon, C. Emmanouilides, A. Raubitschek, N. Janakiraman, J. Gutheil, R.J. Schilder, S. Spies, D.H. Silverman, and A.J. Grillo-Lopez Radioimmunotherapy of relapsed non-Hodgkin's lymphoma with zevalin, a 90Y-labeled anti-CD20 monoclonal antibody Clin. Cancer Res. 5 1999 3281s 3286s
40. H. Kobayashi, S. Kawamoto, T. Saga, N. Sato, A. Hiraga, T. Ishimori, J. Konishi, K. Togashi, and M.W. Brechbiel Positive effects of polyethylene glycol conjugation to generation-4 polyamidoamine dendrimers as macromolecular MR contrast agents Magn. Reson. Med. 46 2001 781 788
41. H. Kobayashi, S. Kawamoto, R.A. Star, T.A. Waldmann, M.W. Brechbiel, and P.L. Choyke Activated clearance of a biotinylated macromolecular MRI contrast agent from the blood pool using an avidin chase Bioconjug. Chem. 14 2003 1044 1047
42. H. Kobayashi, T. Saga, S. Kawamoto, N. Sato, A. Hiraga, T. Ishimori, J. Konishi, K. Togashi, and M.W. Brechbiel Dynamic micro-magnetic resonance imaging of liver micrometastasis in mice with a novel liver macromolecular magnetic resonance contrast agent DAB-Am64-(1B4M-Gd)(64) Cancer Res. 61 2001 4966 4970
43. H. Kobayashi, S. Kawamoto, T. Saga, N. Sato, A. Hiraga, T. Ishimori, Y. Akita, M.H. Mamede, J. Konishi, K. Togashi, and M.W. Brechbiel Novel liver macromolecular MR contrast agent with a polypropylenimine diaminobutyl dendrimer core: comparison to the vascular MR contrast agent with the polyamidoamine dendrimer core Magn. Reson. Med. 46 2001 795 802
44. H. Kobayashi, S. Kawamoto, T. Saga, N. Sato, T. Ishimori, J. Konishi, K. Ono, K. Togashi, and M.W. Brechbiel Avidin-dendrimer-(1B4M-Gd)(254): a tumor-targeting therapeutic agent for gadolinium neutron capture therapy of intraperitoneal disseminated tumor which can be monitored by MRI Bioconjug. Chem. 12 2001 587 593
45. H. Kobayashi, N. Sato, S. Kawamoto, T. Saga, A. Hiraga, T.L. Haque, T. Ishimori, J. Konishi, K. Togashi, and M.W. Brechbiel Comparison of the macromolecular MR contrast agents with ethylenediamine-core versus ammonia-core generation-6 polyamidoamine dendrimer Bioconjug. Chem. 12 2001 100 107
46. H. Kobayashi, N. Sato, S. Kawamoto, T. Saga, A. Hiraga, T. Ishimori, J. Konishi, K. Togashi, and M.W. Brechbiel 3D MR angiography of intratumoral vasculature using a novel macromolecular MR contrast agent Magn. Reson. Med. 46 2001 579 585
47. K. Shirakawa, H. Kobayashi, Y. Heike, S. Kawamoto, M.W. Brechbiel, F. Kasumi, T. Iwanaga, F. Konishi, M. Terada, and H. Wakasugi Hemodynamics in vasculogenic mimicry and angiogenesis of inflammatory breast cancer xenograft Cancer Res. 62 2002 560 566
48. H. Kobayashi, K. Shirakawa, S. Kawamoto, T. Saga, N. Sato, A. Hiraga, I. Watanabe, Y. Heike, K. Togashi, J. Konishi, M.W. Brechbiel, and H. Wakasugi Rapid Accumulation and Internalization of Radiolabeled Herceptin in an Inflammatory Breast Cancer Xenograft with Vasculogenic Mimicry Predicted by the Contrast-enhanced Dynamic MRI with the Macromolecular Contrast Agent G6-(1B4M-Gd)(256) Cancer Res. 62 2002 860 866
49. H. Kobayashi, N. Sato, S. Kawamoto, T. Saga, A. Hiraga, T.L. Haque, T. Ishimori, J. Konishi, K. Togashi, and M.W. Brechbiel A novel intravascular macromolecular MR contrast agent with generation-4 polyamidoamine dendrimer core: accelerated renal excretion with co-injection of lysine Magn. Reson. Med. 46 2001 457 464
50. A.T. Yordanov, H. Kobayashi, S.J. English, K. Reijnders, D. Milenic, M.C. Krishna, J.B. Mitchell, and M.W. Brechbiel Gadolinium-labeled dendrimers as biometric nanoprobes to detect vascular permeability J. Mater. Chem. 13 2003 1523 1525
51. H. Kobayashi, K. Reijnders, S. English, A.T. Yordanov, D.E. Milenic, A.L. Sowers, D. Citrin, M.C. Krishna, T.A. Waldmann, J.B. Mitchell, and M.W. Brechbiel Application of a macromolecular contrast agent for detection of alterations of tumor vessel permeability induced by radiation Clin. Cancer Res. 10 2004 7712 7720
52. H. Kobayashi, S. Kawamoto, S. Jo, N. Sato, T. Saga, A. Hiraga, J. Konishi, S. Hu, K. Togashi, M.W. Brechbiel, and R.A. Star Renal tubular damage detected by dynamic micro-MRI with a dendrimer-based MR contrast agent Kidney Int. 61 2002 1980 1985
53. H. Kobayashi, S. Kawamoto, R.A. Star, T.A. Waldmann, Y. Tagaya, and M.W. Brechbiel Micro-magnetic resonance lymphangiography in mice using a novel dendrimer-based magnetic resonance imaging contrast agent Cancer Res. 63 2003 271 276
54. R.C. Brasch Rationale and applications for macromolecular Gd-based contrast agents Magn. Reson. Med. 22 1991 282 287 (discussion 300-283)
55. C.F. vanDijke, R.C. Brasch, T.P. Roberts, N. Weidner, A. Mathur, D.M. Shames, J.S. Mann, F. Demsar, P. Lang, and H.C. Schwickert Mammary carcinoma model: correlation of macromolecular contrast-enhanced MR imaging characterizations of tumor microvasculature and histologic capillary density Radiology 198 1996 813 818
56. T.M. Behr, R.M. Sharkey, M.E. Juweid, R.D. Blumenthal, R.M. Dunn, G.L. Griffiths, H.J. Bair, F.G. Wolf, W.S. Becker, and D.M. Goldenberg Reduction of the renal uptake of radiolabeled monoclonal antibody fragments by cationic amino acids and their derivatives Cancer Res. 55 1995 3825 3834
57. 99mTc-labeled anti-Tac dsFv Cancer Res. 56 1996 3788 3795
58. H. Kobayashi, C.H. Kao, R.J. Kreitman, N. Le, M.K. Kim, M.W. Brechbiel, C.H. Paik, I. Pastan, and J.A. Carrasquillo Pharmacokinetics of 111In- and 125I-labeled antiTac single-chain Fv recombinant immunotoxin J. Nucl. Med. 41 2000 755 762
59. V.V. Sinitsyn, A.G. Mamontova, Y.Y. Checkneva, A.A. Shnyra, and S.P. Domogatsky Rapid blood clearance of biotinylated IgG after infusion of avidin J. Nucl. Med. 30 1989 66 69
60. H. Kobayashi, H. Sakahara, M. Hosono, Z.S. Yao, S. Toyama, K. Endo, and J. Konishi Improved clearance of radiolabeled biotinylated monoclonal antibody following the infusion of avidin as a chase without decreased accumulation in the target tumor J. Nucl. Med. 35 1994 1677 1684
61. G. Paganelli, P. Magnani, F. Zito, E. Villa, F. Sudati, L. Lopalco, C. Rossetti, M. Malcovati, F. Chiolerio, and E. Seccamani Three-step monoclonal antibody tumor targeting in carcinoembryonic antigen-positive patients Cancer Res. 51 1991 5960 5966
62. M. Chinol, P. Casalini, M. Maggiolo, S. Canevari, E.S. Omodeo, P. Caliceti, F.M. Veronese, M. Cremonesi, F. Chiolerio, E. Nardone, A.G. Siccardi, and G. Paganelli Biochemical modifications of avidin improve pharmacokinetics and biodistribution, and reduce immunogenicity Br. J. Cancer. 78 1998 189 197
63. H. Dafni, T. Israely, Z.M. Bhujwalla, L.E. Benjamin, and M. Neeman Overexpression of vascular endothelial growth factor 165 drives peritumor interstitial convection and induces lymphatic drain: magnetic resonance imaging, confocal microscopy, and histological tracking of triple-labeled albumin Cancer Res. 62 2002 6731 6739
64. P.L. Choyke, J.A. Frank, M.E. Girton, S.W. Inscoe, M.J. Carvlin, J.L. Black, H.A. Austin, and A.J. Dwyer Dynamic Gd-DTPA-enhanced MR imaging of the kidney: experimental results Radiology 170 1989 713 720
65. J.A. Frank, P.L. Choyke, M.E. Girton, H.A. Austin, C. Sievenpiper, S.W. Inscoe, J.L. Black, M.J. Carvlin, and A.J. Dwyer Gadolinium-DTPA enhanced dynamic MR imaging in the evaluation of cisplatinum nephrotoxicity J. Comput. Assist. Tomogr. 13 1989 448 459
66. J.A. Frank, P.L. Choyke, H.A. Austin, and M.E. Girton Functional MR of the kidney Magn. Reson. Med. 22 1991 319 323
67. J.W. Dear, H. Kobayashi, S. Jo, M.K. Holly, P.S.T. Yuen, M.W. Brechbiel, and R.A. Star Dendrimer-enhanced MRI as a diagnostic and prognostic biomarker of sepsis-induced acute renal failure in aged mice Kidney Int. 67 2005 2159 2167
68. H. Kobayashi, S. Kawamoto, M.W. Brechbiel, S.K. Jo, X. Hu, T. Yang, B.A. Diwan, T.A. Waldmann, J. Schnermann, P.L. Choyke, and R.A. Star Micro-MRI methods to detect renal cysts in mice Kidney Int. 65 2004 1511 1516
69. H. Kobayashi, S. Jo, S. Kawamoto, H. Yasuda, X. Hu, M.V. Knopp, M.W. Brechbiel, P.L. Choyke, and R.A. Star Polyamine dendrimer-based MRI contrast agents for the functional kidney imaging to diagnose the acute renal failure J. Magn. Reson. Imaging 20 2004 512 518
70. H. Kobayashi, S. Kawamoto, Y. Sakai, P.L. Choyke, R.A. Star, M.W. Brechbiel, N. Sato, Y. Tagaya, J.C. Morris, and T.A. Waldmann Lymphatic drainage imaging of breast cancer in mice by micro-magnetic resonance lymphangiography using a nano-size paramagnetic contrast agent J. Natl. Cancer Inst. 96 2004 703 708
71. Y. Fujimoto, Y. Okuhata, S. Tyngi, Y. Namba, and N. Oku Magnetic resonance lymphography of profundus lymph nodes with liposomal gadolinium-diethylenetriamine pentaacetic acid Biol. Pharm. Bull. 23 2000 97 100
72. L. Harika, R. Weissleder, K. Poss, C. Zimmer, M.I. Papisov, and T.J. Brady MR lymphography with a lymphotropic T1-type MR contrast agent: Gd-DTPA-PGM Magn. Reson. Med. 33 1995 88 92
73. B. Misselwitz, J. Platzek, B. Raduchel, J.J. Oellinger, and H.J. Weinmann Gadofluorine 8 1999 190 195
74. B. Misselwitz, H. Schmitt-Willich, M. Michaelis, and J.J. Oellinger Interstitial magnetic resonance lymphography using a polymeric t1 contrast agent: initial experience with Gadomer-17 Invest. Radiol. 37 2002 146 151
75. V. Elste, S. Wagner, M. Taupitz, D. Pfefferer, M. Kresse, B. Hamm, R. Berg, K.J. Wolf, and W. Semmler Magnetic resonance lymphography in rats: effects of muscular activity and hyperthermia on the lymph node uptake of intravenously injected superparamagnetic iron oxide particles Acad. Radiol. 3 1996 660 666
76. B. Hamm, M. Taupitz, P. Hussmann, S. Wagner, and K.J. Wolf MR lymphography with iron oxide particles: dose-response studies and pulse sequence optimization in rabbits AJR Am. J. Roentgenol. 158 1992 183 190
77. F. Rety, O. Clement, N. Siauve, C.A. Cuenod, F. Carnot, M. Sich, A. Buisine, and G. Frija MR lymphography using iron oxide nanoparticles in rats: pharmacokinetics in the lymphatic system after intravenous injection J. Magn. Reson. Imaging 12 2000 734 739
78. T. Tanoura, M. Bernas, A. Darkazanli, E. Elam, E. Unger, M.H. Witte, and A. Green MR lymphography with iron oxide compound AMI-227: studies in ferrets with filariasis AJR Am. J. Roentgenol. 159 1992 875 881
79. M. Taupitz, S. Wagner, B. Hamm, A. Binder, and D. Pfefferer Interstitial MR lymphography with iron oxide particles: results in tumor-free and VX2 tumor-bearing rabbits AJR Am. J. Roentgenol. 161 1993 193 200
80. P. Vassallo, C. Matei, W.D. Heston, S.J. McLachlan, J.A. Koutcher, and R.A. Castellino Characterization of reactive versus tumor-bearing lymph nodes with interstitial magnetic resonance lymphography in an animal model Invest. Radiol. 30 1995 706 711
81. R. Weissleder, J.F. Heautot, B.K. Schaffer, N. Nossiff, M.I. Papisov, A. Bogdanov Jr., and T.J. Brady MR lymphography: study of a high-efficiency lymphotrophic agent Radiology 191 1994 225 230
82. H. Kobayashi, S. Kawamoto, P.L. Choyke, N. Sato, M.V. Knopp, R.A. Star, T.A. Waldmann, Y. Tagaya, and M.W. Brechbiel Comparison of dendrimer-based macromolecular contrast agents for dynamic micro-magnetic resonance lymphangiography Magn. Reson. Med. 50 2003 758 766
83. M. Sugaya, T. Watanabe, A. Yang, M.F. Starost, H. Kobayashi, A.M. Atkins, D.L. Borris, E.A. Hanan, D. Schimel, M.A. Bryant, N. Roberts, M. Skobe, K.A. Staskus, P. Kaldis, and A. Blauvelt Lymphatic dysfunction in transgenic mice expressing KSHV k-cyclin under the control of the VEGFR-3 promoter Blood 105 2005 2356 2363
84. E.C. Wiener, S. Konda, A. Shadron, M. Brechbiel, and O. Gansow Targeting dendrimer-chelates to tumors and tumor cells expressing the high-affinity folate receptor Invest. Radiol. 32 1997 748 754
85. S.D. Konda, M. Aref, M. Brechbiel, and E.C. Wiener Development of a tumor-targeting MR contrast agent using the high-affinity folate receptor: work in progress Invest. Radiol. 35 2000 50 57
86. H. Gupta, and R. Weissleder Targeted contrast agents in MR imaging Magn. Reson. Imaging Clin. N. Am. 4 1996 171 184
87. D.A. Sipkins, D.A. Cheresh, M.R. Kazemi, L.M. Nevin, M.D. Bednarski, and K.C. Li Detection of tumor angiogenesis in vivo by alphaVbeta3-targeted magnetic resonance imaging Nat. Med. 4 1998 623 626